OBJECTIVE. Theaimof thisstudywastoassess therolesof transrectal colorDoppler andgray-scale sonography in revealing prostatic cancer,using biopsy as the referencestandard. SUBJECTSAND METHODS. Twohundred fifty-sixpatients referred forurologic studies underwent transrectal sonography using gray-scale and color Doppler scanning. All abnor mal areas shown on gray-scale or color Doppler sonography or both were targeted and biopsies were performed. The patients also underwent random sextant biopsies. All biopsies were mdi viduallycorrelatedwith histopathologic findingsandall resultswereanalyzed. RESULTS.Cancer wasfoundonbiopsyin 100patients (39%),andequivocal sonographicresults or prostatic intraepithelial neoplasia was found in 22 other patients (9%). In 16 of the patients in whom cancer was detected, the tumors were correctly revealed only with color Dop pIer sonography.These 16patients had a meanGleason scoreof 6.4 (range, 5â€"8). Biopsy find ings in these 16 patients showed eight patients with extensive lesions, three with moderate lesions, and five with minimal lesions. However, in nine other patients with cancer (9% of can cers detected), both gray-scale and color Doppler sonography failed to reveal lesions that were found on sextant biopsy. An analysis showed that, although highly sensitive, color Doppler sonography wassomewhatlessspecificthangray-scalesonography. CONCLUSION. ColorDopplersonography should become a routinepartof transrectalsonography of theprostateglandto improvedetectionandtargetingoflesions.The practiceof performing random sextant biopsies should also continue. P rostatic cancer is the most common malignancy in the American male population. Although widely ac ceptedand usedin the diagnosisof prostatic cancer, transrectal sonography has limitations.Prostaticcarcinomasmay be isoechoicI 1] and consequently not visualized on gray-scale sonography. Conversely, the most common sonographic appearance for prostate carci nomaâ€"theperipheral zone hypoechoic le sionâ€"canalso, on histopathologic examination of biopsy specimens, be found to represent a be nign lesion [2, 31.Limitations such as these may be partly over come by advances in technique. Several reports To evaluate the role of color Doppler transrectal sonography in detecting prostatic cancer in referred urologic patients, we pro spectively compared its usefulness with that of gray-scale imaging (keeping in mind the role of sextant biopsies) and correlated the results with biopsy findings. Subjects and MethodsThe population in this study consisted of 256 consecutive patients referred by urologists during theperiodbetween April andSeptember 1996. The patientswere40â€"84 yearsold (meanage,64years). Forty-threepatients(17%) were referredbecauseof an abnormality found on digital rectal examination, I 17 (46%) because of a raised (or rising) level of prostate-specific antigen (PSA), 90 (35%) because of botha raisedlevelof PSAandanabnormality on
A double blind controlled trial was carried out to investigate the method of controlling neonatal staphylococcal disease (NSD) by passive immunization. A group of 166 pregnant women were randomly immunized with a monovalent capsular polysaccharide antigen or with poliomyelitis vaccine (Salk-type) used as "placebo." After delivery, mothers and babies were followed-up at weekly intervals for six weeks. Episodes of staphylococcal disease were recorded. Staphylococcal hemagglutinating antibodies (SHA) were measured in blood specimens collected from mothers and babies before immunization, at birth, and six weeks after birth. The results showed no demonstrable protecting effects against NSD, while paired seras had high levels of SHA titers. This lack of success is ascribed to the type of vaccine used. Further trials with an improved polyvalent capsular staphylococcal antigen are recommended.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.